Signal active
Organization
Contact Information
Overview
PBD Biotech is a clinical-stage diagnostic company and pioneer in phage-based diagnostics. PBD is focused on the development of Actiphage for the detection of tuberculosis in latent TB screening and drug management.
About
Biotechnology, Medical, Medical Device
2014
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
PBD Biotech headquartered in Europe, operates in the Biotechnology, Medical, Medical Device sector. The company focuses on Biotechnology and has secured $278.3M in funding across 48 round(s). With a team of 1-10 employees, PBD Biotech is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - PBD Biotech, raised $256.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
4
2
0
$5.8M
Details
2
PBD Biotech has raised a total of $5.8M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2018 | Seed | 517.8K | ||
2017 | Seed | 256.0K |
Investors
PBD Biotech is funded by 11 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Mark Wilcockson | - | FUNDING ROUND - Mark Wilcockson | 2.7M |
PBD Biotech | - | FUNDING ROUND - PBD Biotech | 2.7M |
Anglia Capital Group | - | FUNDING ROUND - Anglia Capital Group | 256.0K |
PBD Biotech | - | FUNDING ROUND - PBD Biotech | 256.0K |
Recent Activity
There is no recent news or activity for this profile.